sarcosine has been researched along with ketamine in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 3 (50.00) | 2.80 |
Authors | Studies |
---|---|
Pettinger, WA; Tanaka, K | 1 |
Hong, CJ; Huang, YH; Tsai, SJ; Yang, SY | 1 |
Chan, MH; Chen, HH; Chen, YC; Lee, MY; Lin, JC | 1 |
Chan, MH; Chen, HH; Chen, ST; Hsieh, CP; Huang, CM; Lee, MY | 1 |
Cheng, YJ; Lane, HY; Lin, CH | 1 |
Akhtar, A; Kuhad, A; Kumar, A; Sah, SP | 1 |
1 review(s) available for sarcosine and ketamine
Article | Year |
---|---|
Ketamine, benzoate, and sarcosine for treating depression.
Topics: Animals; Antidepressive Agents; Benzoates; Depression; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate; Sarcosine | 2023 |
5 other study(ies) available for sarcosine and ketamine
Article | Year |
---|---|
Renin release and ketamine-induced cardiovascular stimulation in the rat.
Topics: Alanine; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Interactions; Heart Rate; Hemodynamics; Ketamine; Kidney; Nephrectomy; Propranolol; Rats; Renin; Sarcosine; Stimulation, Chemical; Time Factors | 1974 |
The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats.
Topics: Animals; Antipsychotic Agents; Cerebral Cortex; Disease Models, Animal; Glycine Plasma Membrane Transport Proteins; Humans; Ketamine; Motor Activity; Neural Inhibition; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Sarcosine; Schizophrenia | 2010 |
N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Exploratory Behavior; Fear; Hyperkinesis; Immobility Response, Tonic; Ketamine; Locomotion; Male; Memory Disorders; Mice; Mice, Inbred ICR; Prepulse Inhibition; Sarcosine | 2016 |
N, N-dimethylglycine Protects Behavioral Disturbances and Synaptic Deficits Induced by Repeated Ketamine Exposure in Mice.
Topics: Animals; Ketamine; Long-Term Potentiation; Male; Mice; Mice, Inbred ICR; Receptors, N-Methyl-D-Aspartate; Sarcosine | 2021 |
Sarcosine (glycine transporter inhibitor) attenuates behavioural and biochemical changes induced by ketamine, in the rat model of schizophrenia.
Topics: Animals; Glycine Plasma Membrane Transport Proteins; Ketamine; Neuroinflammatory Diseases; Quality of Life; Rats; Receptors, N-Methyl-D-Aspartate; Sarcosine; Schizophrenia | 2023 |